Lishan Aklog - Feb 18, 2022 Form 4 Insider Report for Lucid Diagnostics Inc. (LUCD)

Role
Chief Executive Officer, Director
Signature
/s/ Lishan Aklog
Stock symbol
LUCD
Transactions as of
Feb 18, 2022
Transactions value $
$0
Form type
4
Date filed
2/23/2022, 07:13 PM
Previous filing
Jan 10, 2022
Next filing
Apr 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LUCD Employee stock option (right to buy) Award $0 +75K $0.00 75K Feb 18, 2022 Common stock 75K $3.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 12 quarterly installments, with first installment vesting March 31, 2022.